Health
Healthcare providers working with tissue-based wound care products need clear information about available materials, product configurations, and handling requirements. Access to detailed product information helps clinical teams understand the characteristics of different biological tissue options.
Acesso Biologics is a Las Vegas-based regenerative medicine company focused on making biological tissue products available to healthcare professionals. Its portfolio includes amniotic membrane allografts designed for wound covering and protection, with multiple configurations to address different product requirements.
The company combines its product portfolio with educational resources and information intended to support healthcare professionals as they review amniotic tissue materials.
Headquartered in Las Vegas, Nevada, Acesso Biologics operates in the regenerative medicine field, supplying biological tissue products to qualified healthcare providers, clinical facilities, and authorized distributors.
The company's product portfolio focuses on amniotic membrane allografts, which are derived from human placental tissue and processed for professional use.
Under the leadership of CEO and Chairman Michael Aquino, the company emphasizes access to regenerative medicine products and the information healthcare professionals need to understand its offerings.
Its website provides details about available products, tissue configurations, storage requirements, and technical documentation.
Healthcare facilities may need information about different tissue configurations when reviewing products for their clinical inventory.
Acesso Biologics supplies amniotic membrane allografts through its Acesso and NeoStim product lines.
The catalog includes single-layer, dual-layer, and triple-layer configurations, with individual products identified by their composition and technical specifications.
Products featured in the catalog include Acesso DL, Acesso AC, Acesso TL, NeoStim, and NeoStim DL.
According to the company's product information, its allografts are terminally sterilized and packaged for room-temperature storage. The stated shelf life is up to five years from the date of manufacture.
These characteristics provide practical information for healthcare organizations managing product storage and inventory. Individual product instructions remain important when determining appropriate handling requirements.
Amniotic membrane products are not all constructed in the same way. Their physical composition and number of tissue layers can differ.
Single-layer membranes contain one amniotic layer and have a thinner profile than multilayer configurations.
Dual-layer membranes combine amnion and chorion tissue, producing a different physical structure.
Triple-layer configurations contain three layers and represent another option within the company's product portfolio.
Acesso Biologics also publishes educational information about the differences between amniotic membrane layers, including their composition and structural characteristics.
These distinctions help explain product terminology. The number of layers alone does not determine clinical suitability, and individual product selection remains the responsibility of qualified healthcare professionals.
Quality documentation is an important consideration for organizations working with human tissue products.
Acesso Biologics states that its contract manufacturing operations follow applicable FDA regulations, including Good Tissue Practices.
The company also describes the use of controlled manufacturing procedures and third-party testing as part of its quality approach.
These statements reflect the company's published manufacturing practices and should not be interpreted as independent regulatory certification or product approval.
Healthcare professionals can request product specifications and instructions for use to obtain additional technical information about individual materials.
Acesso Biologics serves healthcare professionals, clinical facilities, and authorized distribution partners seeking information about amniotic tissue allografts.
Alongside its product catalog, the company provides educational articles explaining tissue characteristics, membrane configurations, and related regenerative medicine topics.
Its team also handles requests concerning product documentation, availability, and distributor information.